##gff-version 3
##sequence-region Q00613 1 529
Q00613	UniProtKB	Chain	1	529	.	.	.	ID=PRO_0000124567;Note=Heat shock factor protein 1	
Q00613	UniProtKB	Region	15	120	.	.	.	Note=DNA-binding domain;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26727489,ECO:0000269|PubMed:7935471;Dbxref=PMID:26727489,PMID:7935471	
Q00613	UniProtKB	Region	130	203	.	.	.	Note=Hydrophobic repeat HR-A/B;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Region	203	224	.	.	.	Note=D domain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10747973;Dbxref=PMID:10747973	
Q00613	UniProtKB	Region	221	310	.	.	.	Note=Regulatory domain;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7760831;Dbxref=PMID:7760831	
Q00613	UniProtKB	Region	371	529	.	.	.	Note=Transactivation domain;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7623826,ECO:0000269|PubMed:7760831;Dbxref=PMID:7623826,PMID:7760831	
Q00613	UniProtKB	Region	384	409	.	.	.	Note=Hydrophobic repeat HR-C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Motif	412	420	.	.	.	Note=9aaTAD;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17467953;Dbxref=PMID:17467953	
Q00613	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19413330;Dbxref=PMID:19413330	
Q00613	UniProtKB	Modified residue	80	80	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19229036,ECO:0000269|PubMed:24581496;Dbxref=PMID:19229036,PMID:24581496	
Q00613	UniProtKB	Modified residue	91	91	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Modified residue	118	118	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24581496,ECO:0000269|PubMed:26754925;Dbxref=PMID:24581496,PMID:26754925	
Q00613	UniProtKB	Modified residue	121	121	.	.	.	Note=Phosphoserine%3B by MAPKAPK2;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15760475,ECO:0000269|PubMed:16278218;Dbxref=PMID:15760475,PMID:16278218	
Q00613	UniProtKB	Modified residue	142	142	.	.	.	Note=Phosphothreonine%3B by CK2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12659875;Dbxref=PMID:12659875	
Q00613	UniProtKB	Modified residue	150	150	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Modified residue	188	188	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Modified residue	208	208	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Modified residue	216	216	.	.	.	Note=Phosphoserine%3B by PLK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794143;Dbxref=PMID:18794143	
Q00613	UniProtKB	Modified residue	230	230	.	.	.	Note=Phosphoserine%3B by CAMK2A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11447121,ECO:0000269|PubMed:15760475;Dbxref=PMID:11447121,PMID:15760475	
Q00613	UniProtKB	Modified residue	275	275	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8940068;Dbxref=PMID:8940068	
Q00613	UniProtKB	Modified residue	292	292	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15760475;Dbxref=PMID:15760475	
Q00613	UniProtKB	Modified residue	298	298	.	.	.	Note=N6-acetyllysine%3B alternate;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Modified residue	303	303	.	.	.	Note=Phosphoserine%3B by GSK3-beta;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:11447121,ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:15760475,ECO:0000269|PubMed:16371476,ECO:0000269|PubMed:8940068,ECO:0000269|PubMed:8946918,ECO:0000269|PubMed:9121459;Dbxref=PMID:23186163,PMID:24275569,PMID:11447121,PMID:12665592,PMID:15760475,PMID:16371476,PMID:8940068,PMID:8946918,PMID:9121459	
Q00613	UniProtKB	Modified residue	307	307	.	.	.	Note=Phosphoserine%3B by MAPK3;Ontology_term=ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:11447121,ECO:0000269|PubMed:15760475,ECO:0000269|PubMed:8940068,ECO:0000269|PubMed:8946918,ECO:0000269|PubMed:9121459,ECO:0000269|PubMed:9535852;Dbxref=PMID:23186163,PMID:11447121,PMID:15760475,PMID:8940068,PMID:8946918,PMID:9121459,PMID:9535852	
Q00613	UniProtKB	Modified residue	314	314	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:15760475;Dbxref=PMID:18220336,PMID:19690332,PMID:20068231,PMID:15760475	
Q00613	UniProtKB	Modified residue	319	319	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15760475;Dbxref=PMID:15760475	
Q00613	UniProtKB	Modified residue	320	320	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21085490,ECO:0000269|PubMed:27189267;Dbxref=PMID:21085490,PMID:27189267	
Q00613	UniProtKB	Modified residue	323	323	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:19690332;Dbxref=PMID:17081983,PMID:19690332	
Q00613	UniProtKB	Modified residue	326	326	.	.	.	Note=Phosphoserine%3B by MAPK12;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:15760475,ECO:0000269|PubMed:27354066;Dbxref=PMID:19690332,PMID:20068231,PMID:15760475,PMID:27354066	
Q00613	UniProtKB	Modified residue	344	344	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15760475;Dbxref=PMID:15760475	
Q00613	UniProtKB	Modified residue	363	363	.	.	.	Note=Phosphoserine%3B by MAPK8;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569,ECO:0000269|PubMed:10747973,ECO:0000269|PubMed:15760475;Dbxref=PMID:18669648,PMID:23186163,PMID:24275569,PMID:10747973,PMID:15760475	
Q00613	UniProtKB	Modified residue	419	419	.	.	.	Note=Phosphoserine%3B by PLK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15661742;Dbxref=PMID:15661742	
Q00613	UniProtKB	Modified residue	444	444	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15760475;Dbxref=PMID:15760475	
Q00613	UniProtKB	Modified residue	524	524	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Cross-link	91	91	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00613	UniProtKB	Cross-link	126	126	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00613	UniProtKB	Cross-link	131	131	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00613	UniProtKB	Cross-link	208	208	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00613	UniProtKB	Cross-link	224	224	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00613	UniProtKB	Cross-link	298	298	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)%3B alternate;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11514557,ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:16371476;Dbxref=PMID:11514557,PMID:12665592,PMID:16371476	
Q00613	UniProtKB	Cross-link	298	298	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q00613	UniProtKB	Alternative sequence	462	489	.	.	.	ID=VSP_002414;Note=In isoform Short. GKQLVHYTAQPLFLLDPGSVDTGSNDLP->AGALHSAAAVPAGPRLRGHREQRPAGAV;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q00613	UniProtKB	Alternative sequence	490	529	.	.	.	ID=VSP_002415;Note=In isoform Short. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q00613	UniProtKB	Mutagenesis	22	22	.	.	.	Note=Inhibits HSE DNA-binding activity and transcriptional activation. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9341107;Dbxref=PMID:9341107	
Q00613	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Loss of nuclear stress bodies localization. Loss of DNA-binding and transcriptional activities upon heat shock. No change in homotrimerization upon heat shock. K->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19229036,ECO:0000269|PubMed:24581496;Dbxref=PMID:19229036,PMID:24581496	
Q00613	UniProtKB	Mutagenesis	80	80	.	.	.	Note=Does not change interaction with XRCC5 and XRCC6. Loss of nuclear stress bodies localization. Decreased nuclear stress bodies localization. Loss of DNA-binding and transcriptional activities upon heat shock. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19229036,ECO:0000269|PubMed:24581496,ECO:0000269|PubMed:26359349;Dbxref=PMID:19229036,PMID:24581496,PMID:26359349	
Q00613	UniProtKB	Mutagenesis	91	91	.	.	.	Note=No effect on sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12665592;Dbxref=PMID:12665592	
Q00613	UniProtKB	Mutagenesis	118	118	.	.	.	Note=Loss of nuclear stress bodies localization. No change in protein abundance. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Mutagenesis	118	118	.	.	.	Note=No change in nuclear stress bodies localization. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Mutagenesis	120	120	.	.	.	Note=No effect on binding HSE nor on transcriptional activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16278218;Dbxref=PMID:16278218	
Q00613	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Increased binding HSE and transcriptional activity. Greatly reduced binding to HSP90AA1. No effect on MAPKAPK2 binding. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16278218;Dbxref=PMID:16278218	
Q00613	UniProtKB	Mutagenesis	121	121	.	.	.	Note=Some inhibition of binding HSE and transcriptional activity. No change in binding HSP90AA1. Inhibits MAPKAPK2 binding. Decreased HSF1-induced expression of HSPA1A mRNA in a IER5-dependent manner%3B when associated with D-307%3B D-314%3B D-323 and D-367. S->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16278218,ECO:0000269|PubMed:26754925;Dbxref=PMID:16278218,PMID:26754925	
Q00613	UniProtKB	Mutagenesis	123	123	.	.	.	Note=No effect on binding HSE nor on transcriptional activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16278218;Dbxref=PMID:16278218	
Q00613	UniProtKB	Mutagenesis	124	124	.	.	.	Note=No effect on binding HSE nor on transcriptional activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16278218;Dbxref=PMID:16278218	
Q00613	UniProtKB	Mutagenesis	126	126	.	.	.	Note=No effect on sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12665592;Dbxref=PMID:12665592	
Q00613	UniProtKB	Mutagenesis	140	140	.	.	.	Note=Leads to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Does not lead to constitutive transactivation activity at 20 degrees Celsius. Decreased DNA-binding activity at 37 degrees Celsius. L->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7623826,ECO:0000269|PubMed:7935471;Dbxref=PMID:7623826,PMID:7935471	
Q00613	UniProtKB	Mutagenesis	142	142	.	.	.	Note=Reduced promoter activity by about 90%25. Almost no transcriptional activity when coexpressed with CK2. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12659875;Dbxref=PMID:12659875	
Q00613	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Leads to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Does not lead to constitutive transactivation activity at 20 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. M->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7623826,ECO:0000269|PubMed:7935471;Dbxref=PMID:7623826,PMID:7935471	
Q00613	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Does not lead to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Loss of DNA-binding activity at 37 degrees Celsius. M->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	147	147	.	.	.	Note=Does not lead to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Loss of DNA-binding activity at 37 degrees Celsius. M->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	150	150	.	.	.	Note=No effect on sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12665592;Dbxref=PMID:12665592	
Q00613	UniProtKB	Mutagenesis	162	162	.	.	.	Note=No effect on sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12665592;Dbxref=PMID:12665592	
Q00613	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Does not lead to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Leads to constitutive homotrimerization and DNA-binding activities at 30 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Leads to constitutive homotrimerization%2C DNA-binding and transactivation activities at 20 degrees Celsius. Decreased DNA-binding activity at 37 degrees Celsius. L->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7623826,ECO:0000269|PubMed:7935471;Dbxref=PMID:7623826,PMID:7935471	
Q00613	UniProtKB	Mutagenesis	189	189	.	.	.	Note=Leads to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. L->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Does not lead to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Leads to constitutive homotrimerization and DNA-binding activities at 30 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Leads to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Decreased DNA-binding activity at 37 degrees Celsius. L->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	193	193	.	.	.	Note=Leads to constitutive homotrimerization and DNA-binding activities at 20 degrees Celsius. Loss of DNA-binding activity at 37 degrees Celsius. L->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	208	208	.	.	.	Note=No change in nuclear stress bodies localization. Increased protein abundance. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Mutagenesis	208	208	.	.	.	Note=No change in nuclear stress bodies localization. No change in protein abundance. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Does not change interaction with XRCC5 and XRCC6. No PLK1-induced phosphorylation in mitosis. Inhibits PLK1-stimulated ubiquitinylation. Increased protein stability. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18794143,ECO:0000269|PubMed:26359349;Dbxref=PMID:18794143,PMID:26359349	
Q00613	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Does not change interaction with XRCC5 and XRCC6. No change in spindle pole localization. Increases weakly PLK1-stimulated ubiquitinylation. No change in protein stability. Increased interaction with BTRC. S->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18794143,ECO:0000269|PubMed:26359349;Dbxref=PMID:18794143,PMID:26359349	
Q00613	UniProtKB	Mutagenesis	216	216	.	.	.	Note=Decreased spindle pole localization. Decreased interaction with BTRC. Increased protein stability. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18794143;Dbxref=PMID:18794143	
Q00613	UniProtKB	Mutagenesis	230	230	.	.	.	Note=No phosphorylation. No change in PLK1-induced phosphorylation in mitosis. No change in DNA-binding activity upon heat shock. Decreased transcriptional activity upon heat shock. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11447121,ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:18794143;Dbxref=PMID:11447121,PMID:12665592,PMID:18794143	
Q00613	UniProtKB	Mutagenesis	230	230	.	.	.	Note=Mimics phosphorylation. No effect on transcriptional activity upon heat shock. S->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11447121,ECO:0000269|PubMed:12665592;Dbxref=PMID:11447121,PMID:12665592	
Q00613	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Reduced increase in heat-induced transcriptional activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9535852;Dbxref=PMID:9535852	
Q00613	UniProtKB	Mutagenesis	275	275	.	.	.	Note=Leads to weak constitutive transactivation activity at room temperature. S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8940068;Dbxref=PMID:8940068	
Q00613	UniProtKB	Mutagenesis	292	292	.	.	.	Note=Weak decreased PLK1-induced phosphorylation. Increased nuclear localization upon heat shock. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15661742;Dbxref=PMID:15661742	
Q00613	UniProtKB	Mutagenesis	296	296	.	.	.	Note=No effect neither on repression of transcriptional activity at control temperature nor on transcriptional activation upon heat shock. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8946918;Dbxref=PMID:8946918	
Q00613	UniProtKB	Mutagenesis	297	297	.	.	.	Note=Slight effect on derepression of transcriptional activity at control temperature and on transcriptional activation upon heat shock. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8946918;Dbxref=PMID:8946918	
Q00613	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Induces derepression of transcriptional activity at control temperature. K->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:8946918;Dbxref=PMID:12665592,PMID:8946918	
Q00613	UniProtKB	Mutagenesis	298	298	.	.	.	Note=No change in nuclear stress bodies localization. Increased protein abundance. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24581496;Dbxref=PMID:24581496	
Q00613	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Abolishes sumoylation. No effect on phosphorylation of S-303 nor of S-307. No change in subcellular location to nuclear stress granules upon heat shock. Loss of colocalization with SUMO1 to nuclear stress granules upon heat shock. Does not change interaction with XRCC5 and XRCC6. No effect on binding to HSE nor on transactivation of HSP70. Increases transcriptional activity in a DAXX-dependent manner. No change in protein abundance. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11514557,ECO:0000269|PubMed:12646186,ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:15016915,ECO:0000269|PubMed:24581496,ECO:0000269|PubMed:26359349,ECO:0000269|PubMed:8946918;Dbxref=PMID:11514557,PMID:12646186,PMID:12665592,PMID:15016915,PMID:24581496,PMID:26359349,PMID:8946918	
Q00613	UniProtKB	Mutagenesis	299	299	.	.	.	Note=No effect on repression of transcriptional activity at control temperature. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8946918;Dbxref=PMID:8946918	
Q00613	UniProtKB	Mutagenesis	300	300	.	.	.	Note=Induces derepression of transcriptional activity at control temperature. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8946918;Dbxref=PMID:8946918	
Q00613	UniProtKB	Mutagenesis	303	303	.	.	.	Note=No phosphorylation nor sumoylation. No change in nuclear stress granules subcellular location upon heat shock. Loss of colocalization with SUMO1 to nuclear stress granules upon heat shock. Slight decrease in transcriptional activity on heat treatment. No change in PLK1-induced phosphorylation in mitosis%2C induces derepression of transcription activation at control temperature%2C abolishes sumoylation and induces 2.5-fold increase in transcriptional activity on heat treatment%3B when associated with A-307. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12646186,ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:18794143,ECO:0000269|PubMed:8946918,ECO:0000269|PubMed:9121459,ECO:0000269|PubMed:9535852;Dbxref=PMID:12646186,PMID:12665592,PMID:18794143,PMID:8946918,PMID:9121459,PMID:9535852	
Q00613	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Mimics phosphorylation. No effect on in vitro sumoylation. Greatly increased transcriptional activity on heat induction. 5-fold derepression of transcriptional activity at control temperature%3B when associated with D-307. S->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:8946918,ECO:0000269|PubMed:9121459,ECO:0000269|PubMed:9535852;Dbxref=PMID:12665592,PMID:8946918,PMID:9121459,PMID:9535852	
Q00613	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Leads to constitutive transactivation activity at room temperature. Inhibits interaction with YWHAE and increases cytoplasmic localization%3B when associated with G-307. S->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12917326,ECO:0000269|PubMed:8940068;Dbxref=PMID:12917326,PMID:8940068	
Q00613	UniProtKB	Mutagenesis	307	307	.	.	.	Note=No phosphorylation. Does not reduce Ser-303 phosphorylation. 1.5%25 increase in transcriptional activity on heat-treatment. No change in PLK1-induced phosphorylation in mitosis%2C induces derepression of transcription activation at control temperature%2C abolishes sumoylation and induces 2.5-fold increase in transcriptional activity on heat treatment%3B when associated with A-303. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12646186,ECO:0000269|PubMed:12665592,ECO:0000269|PubMed:18794143,ECO:0000269|PubMed:8946918,ECO:0000269|PubMed:9121459,ECO:0000269|PubMed:9535852;Dbxref=PMID:12646186,PMID:12665592,PMID:18794143,PMID:8946918,PMID:9121459,PMID:9535852	
Q00613	UniProtKB	Mutagenesis	307	307	.	.	.	Note=5-fold derepression of transcriptional activity at control temperature%3B when associated with D-303. Decreased HSF1-induced expression of HSPA1A mRNA in a IER5-dependent manner%3B when associated with D-121%3B D-314%3B D-323 and D-367. S->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:26754925,ECO:0000269|PubMed:8946918,ECO:0000269|PubMed:9121459;Dbxref=PMID:26754925,PMID:8946918,PMID:9121459	
Q00613	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Leads to constitutive transactivation activity at room temperature. Inhibits interaction with YWHAE and increases cytoplasmic localization%3B when associated with G-303. S->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12917326,ECO:0000269|PubMed:8940068;Dbxref=PMID:12917326,PMID:8940068	
Q00613	UniProtKB	Mutagenesis	309	309	.	.	.	Note=No effect on repression of transcriptional activity at control temperature. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8946918;Dbxref=PMID:8946918	
Q00613	UniProtKB	Mutagenesis	311	311	.	.	.	Note=No effect neither on repression of transcriptional activity at control temperature nor on transcriptional activation upon heat shock. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8946918;Dbxref=PMID:8946918	
Q00613	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Weak decreased PLK1-induced phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15661742;Dbxref=PMID:15661742	
Q00613	UniProtKB	Mutagenesis	314	314	.	.	.	Note=Decreased HSF1-induced expression of HSPA1A mRNA in a IER5-dependent manner%3B when associated with D-121%3B D-307%3B D-323 and D-367. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26754925;Dbxref=PMID:26754925	
Q00613	UniProtKB	Mutagenesis	319	319	.	.	.	Note=Weak decreased PLK1-induced phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15661742;Dbxref=PMID:15661742	
Q00613	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Decreased nuclear localization and transcriptional activity upon heat shock. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21085490;Dbxref=PMID:21085490	
Q00613	UniProtKB	Mutagenesis	320	320	.	.	.	Note=Increased nuclear localization and transcriptional activity upon heat shock. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21085490;Dbxref=PMID:21085490	
Q00613	UniProtKB	Mutagenesis	323	323	.	.	.	Note=Decreased HSF1-induced expression of HSPA1A mRNA in a IER5-dependent manner%3B when associated with D-121%3B D-307%3B D-314 and D-367. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26754925;Dbxref=PMID:26754925	
Q00613	UniProtKB	Mutagenesis	326	326	.	.	.	Note=No phosphorylation. Increased nuclear localization upon heat shock. No effect on oligomerization%2C DNA-binding activities and nuclear localization. Significant decrease in transcriptional activity by heat shock. Decreases transcriptional activity in a DAXX-dependent manner. Does not change interaction with XRCC5 and XRCC6. Weak decreased PLK1-induced phosphorylation. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15016915,ECO:0000269|PubMed:15661742,ECO:0000269|PubMed:15760475,ECO:0000269|PubMed:26359349,ECO:0000269|PubMed:27354066;Dbxref=PMID:15016915,PMID:15661742,PMID:15760475,PMID:26359349,PMID:27354066	
Q00613	UniProtKB	Mutagenesis	326	326	.	.	.	Note=Does not change interaction with XRCC5 and XRCC6. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26359349;Dbxref=PMID:26359349	
Q00613	UniProtKB	Mutagenesis	363	363	.	.	.	Note=Decreases MAPK8-induced phosphorylation and does not negatively regulates transactivating activity upon heat shock. No effect on sumoylation. S->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10747973,ECO:0000269|PubMed:12665592;Dbxref=PMID:10747973,PMID:12665592	
Q00613	UniProtKB	Mutagenesis	367	367	.	.	.	Note=Decreased HSF1-induced expression of HSPA1A mRNA in a IER5-dependent manner%3B when associated with D-121%3B D-307%3B D-314 and D-323. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26754925;Dbxref=PMID:26754925	
Q00613	UniProtKB	Mutagenesis	381	381	.	.	.	Note=No effect on sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12665592;Dbxref=PMID:12665592	
Q00613	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Does not lead to constitutive DNA-binding activity at 20 degrees Celsius. Leads to weak constitutive DNA-binding and homotrimerization activities at 30 degrees Celsius. Decreased DNA-binding activity at 37 degrees Celsius. M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Leads to constitutive DNA-binding and homotrimerization activities at 20 degrees Celsius. Does not lead to constitutive transactivation activity at 20 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. M->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7623826,ECO:0000269|PubMed:7935471;Dbxref=PMID:7623826,PMID:7935471	
Q00613	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Leads to constitutive DNA-binding and homotrimerization activities at 20 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. M->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	395	395	.	.	.	Note=Leads to constitutive DNA-binding and homotrimerization activities at 20 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. L->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	395	395	.	.	.	Note=Leads to constitutive DNA-binding and homotrimerization activities at 20 degrees Celsius. No effect on DNA-binding activity at 37 degrees Celsius. L->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7935471;Dbxref=PMID:7935471	
Q00613	UniProtKB	Mutagenesis	419	419	.	.	.	Note=Does not change interaction with XRCC5 and XRCC6. Decreased nuclear localization upon heat shock. Strongly decreases PLK1-induced phosphorylation. No change in PLK1-induced phosphorylation in mitosis. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15661742,ECO:0000269|PubMed:18794143,ECO:0000269|PubMed:26359349;Dbxref=PMID:15661742,PMID:18794143,PMID:26359349	
Q00613	UniProtKB	Mutagenesis	419	419	.	.	.	Note=Does not change interaction with XRCC5 and XRCC6. S->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26359349;Dbxref=PMID:26359349	
Q00613	UniProtKB	Mutagenesis	527	527	.	.	.	Note=No change in binding HSE nor on transcriptional activity. Decreased binding HSE%3B when associated with A-529. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16278218;Dbxref=PMID:16278218	
Q00613	UniProtKB	Mutagenesis	529	529	.	.	.	Note=No change in binding HSE nor on transcriptional activity. Decreased binding HSE%3B when associated with A-527. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16278218;Dbxref=PMID:16278218	
Q00613	UniProtKB	Helix	17	27	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Helix	29	31	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Turn	32	34	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Beta strand	35	37	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Beta strand	39	42	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5D5U	
Q00613	UniProtKB	Beta strand	44	47	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Helix	49	55	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Helix	57	60	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Helix	66	75	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Beta strand	79	83	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Beta strand	87	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LDU	
Q00613	UniProtKB	Beta strand	96	100	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
Q00613	UniProtKB	Helix	109	114	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5HDN	
